Acorda Therapeutics Shows Off Positive Dalfampridine-ER Data in Post-Stroke Deficits at American Neurological Association 2013 Annual Meeting Acorda Therapeutics Presents Positive Dalfampridine-ER Data in Post-Stroke Deficits at American Neurological Association 2013 Annual Meeting ARDSLEY, N.Y.-- -- Acorda Therapeutics, Inc. today announced data ... (more)
http://www.biospace.com/news_story.aspx?StoryID=311622&full=1
http://www.biospace.com/news_story.aspx?StoryID=311622&full=1
No comments:
Post a Comment